On October 30, 135,159 Bitcoin option contracts worth roughly $11 billion expire on Deribit, with a max pain price of $78,000, about 3.9% below the current $81,179 price. Most contracts (86%) expire worthless, indicating limited immediate market impact. The max pain level signals where option sellers' hedging might pull prices, but it is not a price target. Past expiries show slight post-expiry pullbacks of 2-3%, suggesting any price moves may happen after Friday rather than on it. The market shows no signs of over-leverage, implying relatively stable trading around the expiry.
Bitcoin options expiring on October 30 provide context for cryptocurrency markets. For readers following major cryptocurrencies, here is Pluang's market snapshot as of Oct 29, 2026 22:22 WIB: 34 of 50 major cryptocurrencies rose, 14 fell. EOS rose 8.13% to Rp12,649 with a typical hold time of 87 days. UNI changed by +5.50% at Rp134,843 with 65% sell order activity and 35% buy, held typically for 65 days. EGLD gained 3.55% to Rp63,247 with 69% sell order activity and 31% buy, held typically for 86 days.
The inaugural SportsTech Breakthrough Awards recognized leading companies and technologies advancing sports technology globally. Winners span categories like athlete performance, wearables, AI analytics, fan engagement, and smart stadium solutions, h...
The global Industrial Control System (ICS) Security Market is projected to grow from $17.91 billion in 2026 to $38.48 billion by 2031, at a CAGR of 16.5%. This growth is driven by rising cyberattacks targeting critical infrastructure and the increasi...
AdvantageLumber.com has introduced Sketch-A-Deck, a free online software that simplifies deck design for homeowners and contractors. The tool allows users to draw custom deck layouts, attach them to their homes, and generate build-ready plans with de...
Immunocore Holdings will present Phase 1/2 clinical trial data for brenetafusp alone and combined with KIMMTRAK in treating metastatic uveal melanoma at the 2026 Society for Immunotherapy of Cancer meeting. This trial evaluates safety and efficacy in...
Naples Comprehensive Health (NCH) has completed the first tricuspid valve repair in the US using the PASCAL Precision system following FDA approval. This minimally invasive catheter-based procedure offers a new treatment option for patients with seve...
